PIP markedly reduced CS-induced (crystalline silica) inflammation and fibrosis in vivo by suppressing inflammatory cell infiltration, inflammasome formation, collagen/ECM deposition, and inflammatory and fibrotic mediators
Ma et al., Dual redox responsive assemblies formed from diselenide block copolymers
Injection burden 12 injections most days Best for Independent dose control Cycle driver Compound-specific phasing BPC-157 Loading 250500 mcg, daily Frequency Daily Maintenance 250 mcg, daily Route SubQ TB-500 Loading 2.05.0 mg, 2x/week Frequency 2x/week (loading), 12x/week (maintenance) Maintenance 2.0 mg, 12x/week Route SubQ Example Weekly Schedule (Loading Phase) Monday BPC-157 500 mcg SubQ + TB-500 2.5 mg SubQ Tuesday BPC-157 500 mcg SubQ Wednesday BPC-157 500 mcg SubQ Thursday BPC-157 500 mcg SubQ + TB-500 2.5 mg SubQ Friday BPC-157 500 mcg SubQ Saturday BPC-157 500 mcg SubQ Sunday BPC-157 500 mcg SubQ Use separate sterile syringes for separate-vial draws
For severe cases, a bigger dose might be given first, followed by smaller doses later
Do you have a sense of what physicians might think about having that traditional doctor-patient dynamic upended
This blog examines the science behind muscle-building peptides, focusing on their importance in research